Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein

Journal of General Virology

Volumn 91, Issue 7, 2010, Pages 1823-1827

  Breiman, Adrien ^a   Smith, Geoffrey L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; PROTEIN A34; PROTEIN B5; UNCLASSIFIED DRUG; VIRUS PROTEIN; B5 PROTEIN, VACCINIA VIRUS; MATRIX PROTEIN;

ARTICLE; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; VACCINIA VIRUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TRANSPORT;

VACCINIA VIRUS;

GENE EXPRESSION REGULATION, VIRAL; GLYCOSYLATION; MUTATION; PROTEIN TRANSPORT; VACCINIA VIRUS; VIRAL MATRIX PROTEINS;

EID: 77954168702     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.020677-0     Document Type: Article

References (36)

1. Blasco, R. & Moss, B. (1991). Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J Virol 65, 5910-5920.
2. Blasco, R., Sisler, J. R. & Moss, B. (1993). Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J Virol 67, 3319-3325. (Pubitemid 23143705)
3. Condit, R. C., Moussatche, N. & Traktman, P. (2006). In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res 66, 31-124.
4. Dales, S. & Siminovitch, L. (1961). The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy. J Biophys Biochem Cytol 10, 475-503.
5. Duncan, S. A. & Smith, G. L. (1992). Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J Virol 66, 1610-1621.
6. Earley, A. K., Chan, W. M. & Ward, B. M. (2008). The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J Virol 82, 2161-2169.
7. Engelstad, M. & Smith, G. L. (1993). The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194, 627-637.
8. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
9. Herrera, E., Lorenzo, M. M., Blasco, R. & Isaacs, S. N. (1998). Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J Virol 72, 294-302. (Pubitemid 28048840)
10. Hollinshead, M., Vanderplasschen, A., Smith, G. L. & Vaux, D. J. (1999). Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol 73, 1503-1517. (Pubitemid 29036806)
11. Isaacs, S. N., Wolffe, E. J., Payne, L. G. & Moss, B. (1992). Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J Virol 66, 7217-7224.
12. Katz, E., Wolffe, E. J. & Moss, B. (1997). The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. J Virol 71, 3178-3187. (Pubitemid 27119965)
13. Law, M., Putz, M. M. & Smith, G. L. (2005). An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol 86, 991-1000.
14. Law, M., Carter, G. C., Roberts, K. L., Hollinshead, M. & Smith, G. L. (2006). Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A 103, 5989-5994.
15. Lorenzo, M. M., Herrera, E., Blasco, R. & Isaacs, S. N. (1998). Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail. Virology 252, 450-457.
16. Lorenzo, M. M., Galindo, I., Griffiths, G. & Blasco, R. (2000). Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J Virol 74, 10535-10550.
17. Mathew, E., Sanderson, C. M., Hollinshead, M. & Smith, G. L. (1998). The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J Virol 72, 2429-2438.
18. Mathew, E. C., Sanderson, C. M., Hollinshead, R. & Smith, G. L. (2001). A mutational analysis of the vaccinia virus B5R protein. J Gen Virol 82, 1199-1213. (Pubitemid 32454620)
19. McIntosh, A. A. & Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol 70, 272-281. (Pubitemid 126508795)
20. Olivari, S. & Molinari, M. (2007). Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins. FEBS Lett 581, 3658-3664.
21. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a Mr 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
22. Perdiguero, B., Lorenzo, M. M. & Blasco, R. (2008). Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope. J Virol 82, 2150-2160.
23. Pütz, M. M., Alberini, I., Midgley, C. M., Manini, I., Montomoli, E. & Smith, G. L. (2005). Prevalence of antibodies to vaccinia virus after smallpox vaccination in Italy. J Gen Virol 86, 2955-2960.
24. Roberts, K. L. & Smith, G. L. (2008). Vaccinia virus morphogenesis and dissemination. Trends Microbiol 16, 472-479.
25. Roberts, K. L., Breiman, A., Carter, G. C., Ewles, H. A., Hollinshead, M., Law, M. & Smith, G. L. (2009). Acidic residues in the membraneproximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan- mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol 90, 1582-1591.
26. Roper, R. L., Payne, L. G. & Moss, B. (1996). Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol 70, 3753-3762. (Pubitemid 26157355)
27. Rottger, S., Frischknecht, F., Reckmann, I., Smith, G. L. & Way, M. (1999). Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol 73, 2863-2875.
28. Sanderson, C. M., Frischknecht, F., Way, M., Hollinshead, M. & Smith, G. L. (1998). Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol 79, 1415-1425.
29. Shida, H. (1986). Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150, 451-462.
30. Smith, G. L., Vanderplasschen, A. & Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83, 2915-2931. (Pubitemid 36054337)
31. Takahashi-Nishimaki, F., Funahashi, S., Miki, K., Hashizume, S. & Sugimoto, M. (1991). Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins. Virology 181, 158-164.
32. Turner, P. C. & Moyer, R. W. (2006). The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. Virology 347, 88-99.
33. Wagenaar, T. R. & Moss, B. (2007). Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J Virol 81, 6286-6293.
34. Ward, B. M. & Moss, B. (2000). Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. J Virol 74, 3771-3780.
35. Wolffe, E. J., Isaacs, S. N. & Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol 67, 4732-4741.
36. Wolffe, E. J., Katz, E., Weisberg, A. & Moss, B. (1997). The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J Virol 71, 3904-3915. (Pubitemid 27172405)